Raffa Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Raffa Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482	Buy	2 +1	+100%	+$219	﹤0.01%	1189
2026 Q1	$189	Buy	+1	New	+$175	﹤0.01%	1188
2016 Q4	–	Sell	-10	Closed	-$1.22K	–	889
2016 Q3	$1.22K	Hold	10	–	–	﹤0.01%	364
2016 Q2	$1.41K	Buy	10 +1	+11%	+$147	﹤0.01%	316
2016 Q1	$1.18K	Hold	9	–	–	﹤0.01%	358
2015 Q4	$1.26K	Hold	9	–	–	﹤0.01%	340
2015 Q3	$1.2K	Hold	9	–	–	﹤0.01%	347
2015 Q2	$1.58K	Hold	9	–	–	﹤0.01%	305
2015 Q1	$1.55K	Buy	+9	New	+$1.54K	﹤0.01%	297

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raffa Wealth Management's JAZZ Position: Q2 2026 in Review

Raffa Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 100% in Q2 2026, buying an estimated $219 and bringing the position to 2 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Raffa Wealth Management first reported a position in JAZZ in Q1 2015 and has held it in 9 quarters since. The position peaked at $1.58K in Q2 2015. 602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Raffa Wealth Management held 2 shares of Jazz Pharmaceuticals worth $482 as of Q2 2026.
Raffa Wealth Management bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
Jazz Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1189 holding.
Raffa Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 9 quarters since.
Raffa Wealth Management's Jazz Pharmaceuticals position peaked at $1.58K in Q2 2015.
602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.